App-Quantinova.ai

914 Abstracts

Therapeutic Biomarker Discovery in Idiopathic Pulmonary Fibrosis (IPF) Through Proteomic Analysis of Precision-Cut Lung Slice (PCLS) Supernatants

M. C. An - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

R268712

Outcomes of 12 Months of Treatment with Co-Trimoxazole in Patients with Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis

W. Khokher - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Co-trimoxazole

National Estimates and Predictors for Idiopathic Pulmonary Fibrosis Readmissions

A. M. Abdul Hameed - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

The Differences in Efficacy and Tolerability of Nintedanib Based on the Severity of Idiopathic Pulmonary Fibrosis

M. Kato - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Nintedanib

Correlation of Computed Tomographic Patterns with Morphological Tissue Changes in Idiopathic Pulmonary Fibrosis

K. Ikezoe - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Antifibrotic Risk of Bleeding with Anticoagulation - A Case Report

A. Martirosov - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Pirfenidone

Incidentally Found Gastrointestinal Stromal Tumor in a Lung Transplant Recipient

M. T. Olson - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

Imatinib

Resistant Hyperkalemia After Bactrim in a Lung Transplant Recipient

M. T. Olson - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Idiopathic pulmonary fibrosis

Sodium zirconium cyclosilicate

Persistent Headaches and Ring-Enhancing Lesions in a Lung Transplant Recipient

M. T. Olson - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Idiopathic pulmonary fibrosis

Mycophenolate mofetil

A Retrospective Study on the Protective Effect of InfluenzaVaccination from Developing Idiopathic Pulmonary Fibrosis

S. Jacob - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Idiopathic pulmonary fibrosis

N/A

Phage Immunoprecipitation Sequencing Defines CDHR5 and GIMAP1 as Novel Biomarkers for a Subset of Fibrotic Pulmonary Disorders

V. Upadhyay - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

The Clinical Efficacy of a Mixture of Ivy Leaf Extract and Coptidis Rhizome in Patients with Idiopathic Pulmonary Fibrosis

J. Lee - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Oxygenation Adequacy and Outcomes in Hypoxic Patients

S. S. Patil - American Thoracic Society (ATS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

N/A

Small Leucine-rich Proteoglycan Asporin Represses Cardiac And Pulmonary Fibroblast Activation

Lejla Medzikovic - American Society of Anesthesiologists (ASA) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Angiotensin II

Filters

914 Abstracts